Securities code: Shanghai Rightongene Biotechnology Co.Ltd(688217) securities abbreviation: Shanghai Rightongene Biotechnology Co.Ltd(688217) Announcement No.: 2022023 Shanghai Rightongene Biotechnology Co.Ltd(688217)
Special report on the deposit and actual use of raised funds in 2021
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and integrity of its contents according to law.
In accordance with the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of raised funds by listed companies, the guidelines for the self-discipline supervision of listed companies on the science and Innovation Board of Shanghai Stock Exchange No. 1 – standardized operation, and the Listing Rules of shares on the science and innovation board of Shanghai Stock Exchange, Shanghai Rightongene Biotechnology Co.Ltd(688217) (hereinafter referred to as “the company” or “the company”) the board of directors prepared the special report on the deposit and actual use of raised funds in 2021. The details are as follows:
1、 Basic information of raised funds
(I) actual amount of raised funds and time of fund arrival
According to the reply on Approving the registration of Shanghai Rightongene Biotechnology Co.Ltd(688217) initial public offering of shares (zjxk [2021] No. 1126) issued by China Securities Regulatory Commission, the application for registration of the company’s initial public offering of shares is approved. With the consent of Shanghai Stock Exchange, the company issued 13.9 million RMB common shares (A shares) to the public for the first time. The price of this issuance was 18.42 yuan per share, and the total amount of funds raised was 256038 million yuan. After deducting the issuance cost of 61.241 million yuan (excluding value-added tax), the net amount of funds actually raised was 194797 million yuan. All the funds raised in this offering were in place on May 11, 2021, and verified by Zhonghui Certified Public Accountants (special general partnership). The capital verification report (Zhonghui Keyan [2021] No. 4141) was issued on May 11, 2021.
(II) use and balance of raised funds
The company actually used the raised funds of RMB 554977 million in 2021. As of December 31, 2021, the balance of the raised funds of the company is RMB 210815 million (including the accumulated bank deposit interest of the raised funds received and the net amount deducted from bank handling charges), as follows:
Project amount (10000 yuan)
The total amount of raised funds is 2560380
Less: brokerage underwriting Commission and recommendation fee 320000
The total amount of raised funds received is 2240380
Less: 305440 yuan of self raised funds invested in advance replaced by raised funds
Less: 315.81 yuan of advance payment of issuance expenses replaced by raised funds
Less: amount paid for issuance expenses excluding tax 260828
Less: 249537 Yuan directly invested in the raised project
Less: balance of financial products purchased, time deposits and structured deposits 1200000
Plus: the cumulative collection of financial products, time deposits and structured deposits is 178.22
Interest income net of handling charges
The balance of raised funds on December 31, 2021 was 210815
Note: the data tail difference in the above table is caused by rounding
2、 Management of raised funds
(I) management system of raised funds
In order to standardize the management and use of the company’s raised funds, improve the use efficiency of the raised funds and protect the rights and interests of investors, In accordance with the company law of the people’s Republic of China, the securities law of the people’s Republic of China, the Listing Rules of the science and Innovation Board of Shanghai Stock Exchange, the regulatory guidelines for listed companies No. 2 – regulatory requirements for the management and use of raised funds of listed companies, and the self regulatory guidelines for listed companies on the science and Innovation Board of Shanghai Stock Exchange No. 1 – standardized operation and other relevant laws, regulations and normative documents, Combined with the actual situation of the company, the special account storage system is implemented for the raised funds, the provisions are made for the storage and use of the raised funds, the management of project implementation, the change of investment projects and the supervision of use, and the Shanghai Rightongene Biotechnology Co.Ltd(688217) raised funds management system is formulated.
(II) tripartite supervision agreement of raised funds
In April 2021, the company signed the tripartite supervision agreement on the special account for raised funds with the sponsor Haitong Securities Company Limited(600837) Shanghai Fengxian sub branch, Shanghai Branch of Guangdong Development Bank Co., Ltd. Bank Of Hangzhou Co.Ltd(600926) Shanghai branch and Bank Of Nanjing Co.Ltd(601009) Shanghai Branch, respectively, which defined the rights and obligations of all parties. There is no significant difference between the above agreement and the tripartite supervision agreement (model) on the special account storage of raised funds of Shanghai Stock Exchange, and the company has strictly complied with and performed when using the raised funds.
(III) storage of raised funds in special account
As of December 31, 2021, the storage of raised funds in the special account is as follows:
Unit: RMB / 10000 yuan
Remarks on the balance of raised funds in the account number of the deposit bank
China Merchants Bank Co.Ltd(600036) Shanghai Fengxian sub branch 1219397580109036.02 current account
Guangdong Development Bank Co., Ltd. Shanghai Branch 95508802058919008191092.11 current account
Bank Of Hangzhou Co.Ltd(600926) Shanghai Branch 310104016 Shandong Weida Machinery Co.Ltd(002026) 40634.17 current account
Bank Of Nanjing Co.Ltd(601009) Shanghai Branch 0301230 Shenzhen Guohua Network Security Technology Co.Ltd(000004) 922975.85 current account
Total 210815
3、 Actual use of raised funds this year
(I) comparison table of use of raised funds
As of December 31, 2021, the raised funds actually invested by the company in relevant projects totaled 554977 million yuan. See attached table 1: comparison table of the use of raised funds for specific use.
(II) advance investment and replacement of raised funds
On June 30, 2021, the company held the 17th meeting of the first board of directors and the 12th meeting of the first board of supervisors, deliberated and approved the proposal on using raised funds to replace self raised funds invested in projects invested with raised funds in advance and paid issuance expenses respectively, and agreed to use raised funds to replace paid issuance expenses of RMB 3.1581 million and self raised funds invested in projects invested with raised funds in advance of RMB 30.544 million. For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) on July 2, 2021 The announcement on the adjustment of the amount of raised investment projects and the use of raised funds to replace self raised funds invested in raised investment projects in advance and paid issuance expenses (Announcement No.: 2021005).
As of December 31, 2021, the company has used the raised funds to replace the paid issuance expenses of RMB 3.1581 million and the self raised funds of RMB 30.544 million invested in the investment projects with raised funds in advance. The above replacement matters have been completed.
(III) temporary replenishment of working capital with idle raised funds
During the reporting period, the company did not use idle raised funds to temporarily supplement working capital.
(IV) cash management of idle raised funds
On June 30, 2021, the company held the 17th meeting of the first board of directors and the 12th meeting of the first board of supervisors, deliberated and passed the proposal on using idle raised funds for cash management respectively, and agreed that the company would not affect the construction and implementation of investment projects with raised funds, the use plan of raised funds and the guarantee of raising funds
When the funds are safe, use the temporarily idle raised funds up to 160 million yuan for cash management, purchase investment products with high safety and good liquidity, and meet the capital preservation requirements (including but not limited to)
Principal guaranteed financial products, structured deposits, time deposits, large certificates of deposit, call deposits and agreed deposits
The service life is valid within 12 months from the date of deliberation and approval by the board of directors, which is within the scope and duration of the above limit
Within the time limit, the funds can be recycled and rolled.
As of December 31, 2021, the company used some idle raised funds for cash management, as shown in
Below:
Unit: RMB / 10000 yuan
Entrusted bank product name amount start time end time expected annualized rate of return whether to redeem
Guangfa offers structural deposit of 5 China Vanke Co.Ltd(000002) 021/8/17202111/16 1.00% or 3.30% or
Xianxian sub branch 3.45%
Structural deposit of Guangdong Development Bank 5 China Vanke Co.Ltd(000002) 021 / 11 / 192022 / 5 / 18 1.3% or 3.30% or no
Xianxian sub branch 3.7%
China Merchants Bank Co.Ltd(600036) Fengda certificate of deposit 1 China Vanke Co.Ltd(000002) 021 / 5 / 202021 / 9 / 3 3.78% yes
Xianxian sub branch
Bank Of Nanjing Co.Ltd(601009) upper certificate of deposit 1 China Vanke Co.Ltd(000002) 021 / 8 / 4 2024 / 8 / 4 3.55% no
Shanghai Branch
Bank Of Nanjing Co.Ltd(601009) upper structured deposit 2 China Vanke Co.Ltd(000002) 021 / 8 / 6 2022 / 2 / 9 1.85% or 3.4% or no
Shanghai Branch 3.7%
Bank Of Hangzhou Co.Ltd(600926) upper certificate of deposit 15 Shenzhen Zhongheng Huafa Co.Ltd(000020) 21 / 9 / 162022 / 1 / 24 3.55% no
Shanghai Branch
Bank Of Hangzhou Co.Ltd(600926) upper structured deposit 800. Zoje Resources Investment Co.Ltd(002021) / 8 / 132021 / 11 / 18 1.5% – 3.2% yes
Shanghai Branch
Bank Of Hangzhou Co.Ltd(600926) upper structured deposit 1270 Zoje Resources Investment Co.Ltd(002021) / 9 / 292021 / 11 / 29 1.5% – 2.7% yes
Shanghai Branch
Bank Of Hangzhou Co.Ltd(600926) upper structured deposit 25 Shenzhen Zhongheng Huafa Co.Ltd(000020) 21 / 12 / 3 2022 / 2 / 25 1.5% – 3.2% no
Shanghai Branch
(V) permanent replenishment of working capital or repayment of bank loans with over raised funds
During the reporting period, the company did not use over raised funds to permanently supplement working capital or repay bank loans
Situation.
(VI) changes in the place and mode of implementation of the project invested with raised funds.
During the reporting period, the company did not change the implementation location and implementation mode of the projects invested with raised funds. (VII) use of over raised funds for projects under construction and new projects (including acquisition of assets, etc.)
During the reporting period, the company did not use the over raised funds for projects under construction and new projects (including the acquisition of assets, etc.).
(VIII) use of surplus raised funds
During the reporting period, the company did not use the surplus raised funds for investment projects.
(IX) other information about the use of raised funds
During the reporting period, the company did not use the raised funds.
4、 Change the use of funds for investment projects with raised funds
(I) change of investment projects with raised funds
During the reporting period, there was no change in the investment project of the company’s raised funds.
(II) external transfer or replacement of investment projects with raised funds
During the reporting period, there was no outward transfer of the company’s investment projects with raised funds
